Unidym, Inc., a majority-owned subsidiary of Arrowhead Research Corporation, announced today that U.S. Patent No. 7,265,174 has been issued by the U.S. Patent and Trademark Office. With respect to transparent conductive films, Clemson University has exclusively licensed this patent to Unidym. Unidym is a leader in the development and manufacture of carbon nanotubes for applications in the electronics industry. Unidym, which recently merged with Carbon Nanotechnologies, Inc. (CNI), possesses a foundational patent portfolio that covers nearly every aspect of carbon nanotube manufacturing and processing.
Recent research shows that humans are surprisingly poor at matching a face in a photograph to that seen in real life. The situation is the same with automatic face recognition systems. In today’s surveillance society, correct photo identification is of the utmost importance and with the government’s proposed identity card scheme expected to begin in 200, the ID issue is highly controversial.
Cree, Inc., a leader in LED lighting components, today announced it has achieved R&D results of 129 lumens per watt for a cool-white LED and 99 lumens per watt for a warm-white LED. These are the best results reported for packaged, high-power LEDs, and they clearly indicate that Cree is extending its lead in solid-state lighting through its continued investments in LED technology.
Research by the Advanced Institute of Technology Photonics group scientists on new approaches to displays and lighting technology were recently awarded the best poster prizes at the European Materials Research Society (EMRS), Strasbourg and the International Conference on Optical, Optoelectronic and Photonic Materials and Applications (ICOOPMA), London.
Cree, Inc., a leader in LED lighting components, today announced it has demonstrated light output of more than 1,000 lumens – an amount equivalent to the output level of a standard household light bulb – from a single R&D LED. Cree’s achievement demonstrates continued leadership in the development of LEDs that can make traditional light bulbs obsolete.
The Toronto Association of Business Improvement
Areas (TABIA) today announced that Toronto is joining Raleigh, N.C. in a
citywide initiative to install light-emitting diode (LED) lighting throughout
its infrastructure. The "LED City" program, which was launched in February by
City of Raleigh officials and LED manufacturer Cree, Inc., fosters
collaboration among municipalities as they deploy energy- efficient lighting
to deliver cost savings and environmental benefits.
Scientists have long known that the human body runs like clockwork, guided by a circadian system that responds to daily patterns of light and darkness. Now a team of researchers is developing a personal device to measure daily light intake and activity, which could allow them to predict optimal timing for light therapy to synchronize the circadian clock to the 24-hour solar day and relieve psychosocial stress.
American Elements announced today the formation of a new product group to manage the production, sales and marketing of its quantum dot nanopowder production facilities. The new division was spun off from the Nanometals™ Group and will operate under the tradename AE Quantum Dots.
With its Optotronic OT RGB DMX dimmer, OSRAM has now entered the world of DMX 3-channel dimmers for LED systems. Since DMX supports up to 512 individually addressable channels, the new dimmer lends itself particularly well to creating effect-oriented lighting in discotheques, theatres or concert halls, as well as to the large-area illumination of architecture.
Cooper Industries, Ltd. announced that it has acquired io Lighting, a dedicated light-emitting diode (“LED”) lighting fixture company, and Powerline Communications, Inc., a manufacturer of digital lighting control panels. Expected sales for the two companies in 2007 are approximately $17 million and the combined purchase price is $22 million.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.